Search

everythinglearnresearchcommunity

for

Search:↓

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

Mediterranean diet with fresh herbs and vegetables lowers male hair loss risk.

People with more knowledge about their hair loss condition and those who see it as a serious issue are more likely to seek treatment.

Early hair loss common in Chinese males, linked to family history and smoking; early treatment advised.

Women with hair loss have more androgen receptors in certain hair follicles.

Apoptosis may contribute to hair loss in androgenetic alopecia.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

Fractional lasers could help hair regrowth in androgenic alopecia, but more research is needed to confirm their effectiveness and safety.

Model improves accuracy in predicting hair loss effects.

PRP injections and scalp lifting together improve hair thickness and growth in hair loss patients.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Some skin diseases may indicate a higher risk of metabolic syndrome and related health issues.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Use antiandrogens and other treatments for hair loss.

Treat hair loss with medicine, continue indefinitely.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Oxidative stress contributes to hair graying and loss as we age.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

There may be a link between hair loss and heart disease in women, but more research is needed.

The 1565 nm non-ablative fractional laser is more effective and satisfying than 5% minoxidil for treating hair loss.

Hair loss significantly lowers life quality, especially in young men, with most patients unhappy with treatment effectiveness.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Androgenetic alopecia trials in the U.S. lack racial and ethnic diversity, limiting their applicability.